vs
FRESH DEL MONTE PRODUCE INC（FDP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
FRESH DEL MONTE PRODUCE INC的季度营收约是Royalty Pharma plc的1.6倍（$1.0B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 3.2%，领先31.3%），Royalty Pharma plc同比增速更快（4.8% vs 0.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -4.1%）
鲜德尔蒙农产品公司是全球领先的垂直一体化生鲜及鲜切果蔬、加工果蔬生产、分销及营销企业，注册地位于开曼群岛乔治敦，美国行政总部设在佛罗里达州科勒尔盖布尔斯塞维利亚大道241号。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FDP vs RPRX — 直观对比
营收规模更大
FDP
是对方的1.6倍
$622.0M
营收增速更快
RPRX
高出4.1%
0.6%
净利率更高
RPRX
高出31.3%
3.2%
两年增速更快
RPRX
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $622.0M |
| 净利润 | $32.3M | $214.2M |
| 毛利率 | 10.4% | — |
| 营业利润率 | 4.5% | 62.4% |
| 净利率 | 3.2% | 34.4% |
| 营收同比 | 0.6% | 4.8% |
| 净利润同比 | 59.1% | 2.9% |
| 每股收益（稀释后） | $0.67 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FDPRPRX
| Q4 25 | $1.0B | $622.0M | ||
| Q3 25 | $1.0B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.1B | $568.2M | ||
| Q4 24 | $1.0B | $593.6M | ||
| Q3 24 | $1.0B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润FDPRPRX
| Q4 25 | $32.3M | $214.2M | ||
| Q3 25 | $-29.1M | $288.2M | ||
| Q2 25 | $56.8M | $30.2M | ||
| Q1 25 | $31.1M | $238.3M | ||
| Q4 24 | $20.3M | $208.2M | ||
| Q3 24 | $42.1M | $544.0M | ||
| Q2 24 | $53.6M | $102.0M | ||
| Q1 24 | $26.1M | $4.8M |
毛利率FDPRPRX
| Q4 25 | 10.4% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 7.4% | — |
营业利润率FDPRPRX
| Q4 25 | 4.5% | 62.4% | ||
| Q3 25 | -2.1% | 70.1% | ||
| Q2 25 | 5.8% | 36.3% | ||
| Q1 25 | 4.1% | 94.0% | ||
| Q4 24 | 3.0% | 60.9% | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 6.0% | 50.2% | ||
| Q1 24 | 4.0% | -13.0% |
净利率FDPRPRX
| Q4 25 | 3.2% | 34.4% | ||
| Q3 25 | -2.8% | 47.3% | ||
| Q2 25 | 4.8% | 5.2% | ||
| Q1 25 | 2.8% | 41.9% | ||
| Q4 24 | 2.0% | 35.1% | ||
| Q3 24 | 4.1% | 96.3% | ||
| Q2 24 | 4.7% | 19.0% | ||
| Q1 24 | 2.4% | 0.8% |
每股收益（稀释后）FDPRPRX
| Q4 25 | $0.67 | $0.49 | ||
| Q3 25 | $-0.61 | $0.67 | ||
| Q2 25 | $1.18 | $0.07 | ||
| Q1 25 | $0.64 | $0.55 | ||
| Q4 24 | $0.41 | $0.46 | ||
| Q3 24 | $0.88 | $1.21 | ||
| Q2 24 | $1.12 | $0.23 | ||
| Q1 24 | $0.55 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.7M | $618.7M |
| 总债务越低越好 | $176.2M | $9.0B |
| 股东权益账面价值 | $2.0B | $9.7B |
| 总资产 | $3.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.09× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FDPRPRX
| Q4 25 | $35.7M | $618.7M | ||
| Q3 25 | $97.2M | $938.9M | ||
| Q2 25 | $85.5M | $631.9M | ||
| Q1 25 | $34.4M | $1.1B | ||
| Q4 24 | $32.6M | $929.0M | ||
| Q3 24 | $50.8M | $950.1M | ||
| Q2 24 | $37.8M | $1.8B | ||
| Q1 24 | $42.2M | $843.0M |
总债务FDPRPRX
| Q4 25 | $176.2M | $9.0B | ||
| Q3 25 | $176.7M | $8.9B | ||
| Q2 25 | $205.2M | $8.0B | ||
| Q1 25 | $237.4M | $7.6B | ||
| Q4 24 | $248.9M | $7.6B | ||
| Q3 24 | $274.8M | $7.6B | ||
| Q2 24 | $290.4M | $7.6B | ||
| Q1 24 | $405.8M | $6.1B |
股东权益FDPRPRX
| Q4 25 | $2.0B | $9.7B | ||
| Q3 25 | $2.0B | $9.6B | ||
| Q2 25 | $2.1B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $2.0B | $9.8B | ||
| Q1 24 | $1.9B | $9.9B |
总资产FDPRPRX
| Q4 25 | $3.1B | $19.6B | ||
| Q3 25 | $3.1B | $19.3B | ||
| Q2 25 | $3.2B | $18.3B | ||
| Q1 25 | $3.2B | $17.6B | ||
| Q4 24 | $3.1B | $18.2B | ||
| Q3 24 | $3.2B | $18.0B | ||
| Q2 24 | $3.1B | $17.7B | ||
| Q1 24 | $3.2B | $16.1B |
负债/权益比FDPRPRX
| Q4 25 | 0.09× | 0.92× | ||
| Q3 25 | 0.09× | 0.93× | ||
| Q2 25 | 0.10× | 0.84× | ||
| Q1 25 | 0.12× | 0.78× | ||
| Q4 24 | 0.13× | 0.74× | ||
| Q3 24 | 0.14× | 0.74× | ||
| Q2 24 | 0.15× | 0.78× | ||
| Q1 24 | 0.21× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-17.2M | — |
| 自由现金流率自由现金流/营收 | -1.7% | — |
| 资本支出强度资本支出/营收 | 2.8% | — |
| 现金转化率经营现金流/净利润 | 0.34× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $181.3M | — |
8季度趋势，按日历期对齐
经营现金流FDPRPRX
| Q4 25 | $10.9M | $827.1M | ||
| Q3 25 | $75.0M | $702.6M | ||
| Q2 25 | $113.1M | $364.0M | ||
| Q1 25 | $46.1M | $596.1M | ||
| Q4 24 | $-4.7M | $742.5M | ||
| Q3 24 | $43.5M | $703.6M | ||
| Q2 24 | $125.0M | $658.2M | ||
| Q1 24 | $18.7M | $664.6M |
自由现金流FDPRPRX
| Q4 25 | $-17.2M | — | ||
| Q3 25 | $60.9M | — | ||
| Q2 25 | $101.5M | — | ||
| Q1 25 | $36.1M | — | ||
| Q4 24 | $-22.3M | — | ||
| Q3 24 | $30.1M | — | ||
| Q2 24 | $117.0M | — | ||
| Q1 24 | $6.0M | — |
自由现金流率FDPRPRX
| Q4 25 | -1.7% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 10.3% | — | ||
| Q1 24 | 0.5% | — |
资本支出强度FDPRPRX
| Q4 25 | 2.8% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.1% | — |
现金转化率FDPRPRX
| Q4 25 | 0.34× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 1.99× | 12.06× | ||
| Q1 25 | 1.48× | 2.50× | ||
| Q4 24 | -0.23× | 3.57× | ||
| Q3 24 | 1.03× | 1.29× | ||
| Q2 24 | 2.33× | 6.45× | ||
| Q1 24 | 0.72× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
